Abstract

Osteosarcoma is the most frequent primary bone tumor with poor prognosis. Through RNA-sequencing of 100,987 individual cells from 7 primary, 2 recurrent, and 2 lung metastatic osteosarcoma lesions, 11 major cell clusters are identified based on unbiased clustering of gene expression profiles and canonical markers. The transcriptomic properties, regulators and dynamics of osteosarcoma malignant cells together with their tumor microenvironment particularly stromal and immune cells are characterized. The transdifferentiation of malignant osteoblastic cells from malignant chondroblastic cells is revealed by analyses of inferred copy-number variation and trajectory. A proinflammatory FABP4+ macrophages infiltration is noticed in lung metastatic osteosarcoma lesions. Lower osteoclasts infiltration is observed in chondroblastic, recurrent and lung metastatic osteosarcoma lesions compared to primary osteoblastic osteosarcoma lesions. Importantly, TIGIT blockade enhances the cytotoxicity effects of the primary CD3+ T cells with high proportion of TIGIT+ cells against osteosarcoma. These results present a single-cell atlas, explore intratumor heterogeneity, and provide potential therapeutic targets for osteosarcoma.

Osteosarcomas are difficult to treat and have a limited response to immunotherapy. Here, the authors analyse osteosarcomas at the single-cell level, and identify both the transdifferentiation of malignant cells and an array of immune cells that could have implications for metastasis and immunotherapy.

Details

Title
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Author
Zhou, Yan 1 ; Yang, Dong 2 ; Yang Qingcheng 2 ; Lv Xiaobin 3   VIAFID ORCID Logo  ; Huang, Wentao 4 ; Zhou, Zhenhua 5 ; Wang, Yaling 1   VIAFID ORCID Logo  ; Zhang, Zhichang 2 ; Yuan Ting 2 ; Ding Xiaomin 1 ; Tang, Lina 1   VIAFID ORCID Logo  ; Zhang, Jianjun 1 ; Yin Junyi 1 ; Huang, Yujing 1 ; Yu, Wenxi 1 ; Wang, Yonggang 1 ; Zhou Chenliang 1 ; Yang, Su 1 ; He, Aina 1 ; Sun Yuanjue 1 ; Shen, Zan 1 ; Qian Binzhi 6   VIAFID ORCID Logo  ; Meng, Wei 7 ; Jia, Fei 8 ; Yang, Yao 1 ; Pan Xinghua 7   VIAFID ORCID Logo  ; Chen Peizhan 9   VIAFID ORCID Logo  ; Hu, Haiyan 1 

 Oncology Department of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China (GRID:grid.412528.8) (ISNI:0000 0004 1798 5117) 
 Orthopaedic Department of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China (GRID:grid.412528.8) (ISNI:0000 0004 1798 5117) 
 Central Laboratory of the First Hospital of Nanchang, Nanchang, China (GRID:grid.479689.d) 
 Pathology Department of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China (GRID:grid.412528.8) (ISNI:0000 0004 1798 5117) 
 Changzheng Hospital of Naval Military Medical University, Department of Orthopedic Oncology, Shanghai, China (GRID:grid.413810.f) 
 Queen’s Medical Research Institute, MRC Centre for Reproductive Health & Edinburgh Cancer Research UK Centre, Edinburgh, United Kingdom (GRID:grid.511172.1) (ISNI:0000 0004 0613 128X) 
 Southern Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou, China (GRID:grid.484195.5) 
 Medical College of Jinan University, Department of Biochemistry and Molecular Biology, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548) 
 Shanghai Jiao Tong University School of Medicine, Clinical Research Center, Ruijin Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473302318
Copyright
© The Author(s) 2020. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.